Lumos Pharma Inc. – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from 8-K 39 pages 5,000,000 Shares Newlink Genetics Corporation Underwriting Agreement

from 8-K 36 pages 4,000,000 Shares Newlink Genetics Corporation Underwriting Agreement

from 8-K 2 pages Newlink Genetics Receives Notice of Allowance From Uspto for New Patent Broadly Covering Its D-1mt Ido Pathway Inhibitor

from 8-K 2 pages Newlink Genetics Receives Notice of Allowance From the Japan Patent Office for New Patent Broadly Covering Its Hyperacute® Cancer Immunotherapy Products

from 10-K 1 page Consent of Independent Registered Public Accounting Firm

from 8-K 5 pages Newlink Genetics Corporation Reports Fourth Quarter and Full-Year 2011 Financial Results Conference Call Scheduled for 5:00 Pm Edt March 29, 2012

from 8-K 13 pages Settlement Agreement

from S-1/A 54 pages Newlink Genetics Corporation [ ],000 Shares of Common Stock Underwriting Agreement